Re: Agreement and Plan of Merger and Reorganization by and among Cellect Biotechnology, Inc.

Exhibit 99.2

 

September 24, 2021

Via Email (xxxxxx@xxxxxxxxxxx.xxx)

Xxxxxxx Xxxxx, Ph.D.

Chief Executive Officer

Quoin Pharmaceuticals, Inc. 

00000 Xxxxxxxx Xxxxxx Xxxxx

Ashburn, VA 20148

Re:	Agreement and Plan of Merger and Reorganization by and among Cellect Biotechnology, Inc.
	(“Cellect”), CellMSC, Inc. (“Merger Sub”), and Quoin Pharmaceuticals, Inc. (“Quoin”) dated as of
	March 24, 2021

Dear Xxxxxxx:

This letter sets forth our agreement to amend the Merger Agreement, as we discussed. Effective as of the date hereof, the “Outside Date” (as defined in the Merger Agreement) shall be November 1, 2021. In all other respects, the provisions of the Merger Agreement shall remain in full force and effect.

Please sign below to confirm your agreement to this amendment.

Sincerely,

Xxxx Xxxxxxx

CEO

CELLECT BIOTECHNOLOGY, LTD.

By:	/s/ Xxxx Xxxxxxx
	Xxxx Xxxxxxx
	CEO
CELLMSC, INC.			QUOIN PHARMACEUTICALS, INC.
By:	/s/ Xxxx Xxxxxxx		By:	/s/ Xxxxxxx Xxxxx
	Xxxx Xxxxxxx			Xxxxxxx Xxxxx
	President			Chief Executive Officer